Skip to main content
Top
Gepubliceerd in:

01-08-2016

Impact of nine chronic conditions for US adults aged 65 years and older: an application of a hybrid estimator of quality-adjusted life years throughout remainder of lifetime

Auteurs: Haomiao Jia, Erica I. Lubetkin

Gepubliceerd in: Quality of Life Research | Uitgave 8/2016

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

To estimate quality-adjusted life years (QALY) loss due to each of the following nine chronic conditions—depression, diabetes mellitus, hypertension, heart disease, stroke, emphysema, asthma, arthritis, and cancer.

Methods

We ascertained respondents’ health-related quality of life scores and mortality status from the 2005 to 2008 National Health and Nutrition Examination Survey (NHANES) with mortality follow-up data through December 31, 2011. We included respondents aged 65 years and older (n = 2380). A hybrid estimator was used to calculate QALY from two parts: QALY during the follow-up period and QALY beyond the follow-up period. We calculated QALY by each of the nine chronic conditions.

Results

For persons aged 65 and older, QALY throughout the reminder of lifetime was 12.3 years. After adjusting for age- and sex-related differences, depression had an associated 8.2 years of QALY loss; diabetes, 5.6 years; hypertension, 2.5 years; heart disease, 5.4 years; stroke, 6.4 years; emphysema, 8.0 years; asthma, 4.8 years; arthritis, 0.3 years; and cancer, 2.5 years. Compared to persons without any chronic conditions, persons with one condition had an associated 4.7 years of QALY loss; persons with two conditions, 7.9 years; and persons with three or more conditions, 10.8 years.

Conclusions

This study presents a QALY estimator for respondents in the NHANES-Linked Mortality File and demonstrates the utility of this method to other follow-up data. Continued application of our method would enable the burden of disease to be compared for a range of health conditions and risk factors in the ongoing effort to improve population health.
Literatuur
1.
go back to reference Institute of Medicine. (2012). Living well with chronic illness: A call for public health action. Washington, DC: The National Academies Press. Institute of Medicine. (2012). Living well with chronic illness: A call for public health action. Washington, DC: The National Academies Press.
2.
go back to reference Roglic, G., & Unwin, N. (2010). Mortality attributable to diabetes: Estimates for the year 2010. Diabetes Research and Clinical Practice, 87(1), 15–19.CrossRefPubMed Roglic, G., & Unwin, N. (2010). Mortality attributable to diabetes: Estimates for the year 2010. Diabetes Research and Clinical Practice, 87(1), 15–19.CrossRefPubMed
3.
go back to reference Holmes, J., McGill, S., Kind, P., Bottomley, J., Gillam, S., & Murphy, M. (2000). Health-related quality of life in type 2 diabetes (TARDIS-2). Value in Health, 3(Suppl 1), 47–51.CrossRefPubMed Holmes, J., McGill, S., Kind, P., Bottomley, J., Gillam, S., & Murphy, M. (2000). Health-related quality of life in type 2 diabetes (TARDIS-2). Value in Health, 3(Suppl 1), 47–51.CrossRefPubMed
4.
go back to reference Field, M. J., & Gold, M. R. (Eds.). (1998). Summarizing population health: Directions for the development and application of population metrics. Washington, DC: Institute of Medicine, National Academy Press. Field, M. J., & Gold, M. R. (Eds.). (1998). Summarizing population health: Directions for the development and application of population metrics. Washington, DC: Institute of Medicine, National Academy Press.
5.
go back to reference Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press. Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.
6.
go back to reference Brown, D. S., Jia, H., Zack, M. M., Thompson, W. W., Haddix, A. C., & Kaplan, R. M. (2013). Using health-related quality of life and quality-adjusted life expectancy for effective public health surveillance and prevention. Expert Review of Pharmacoeconomics and Outcomes Research, 13(4), 425–427.CrossRefPubMed Brown, D. S., Jia, H., Zack, M. M., Thompson, W. W., Haddix, A. C., & Kaplan, R. M. (2013). Using health-related quality of life and quality-adjusted life expectancy for effective public health surveillance and prevention. Expert Review of Pharmacoeconomics and Outcomes Research, 13(4), 425–427.CrossRefPubMed
7.
go back to reference Gold, M. R., Stevenson, D., & Fryback, D. G. (2002). HALYS and QALYS and DALYS, Oh My: Similarities and differences in summary measures of population health. Annual Review of Public Health, 23, 115–134.CrossRefPubMed Gold, M. R., Stevenson, D., & Fryback, D. G. (2002). HALYS and QALYS and DALYS, Oh My: Similarities and differences in summary measures of population health. Annual Review of Public Health, 23, 115–134.CrossRefPubMed
8.
go back to reference Murray, C. J., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., et al. (2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: A systematic analysis for the global burden of disease study 2010. Lancet, 380(9859), 2197–2223.CrossRefPubMed Murray, C. J., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., et al. (2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: A systematic analysis for the global burden of disease study 2010. Lancet, 380(9859), 2197–2223.CrossRefPubMed
10.
go back to reference Chiang, C. L. (1984). Statistical inference regarding life table functions. In C. L. Chiang (Ed.), The life table and its applications (pp. 153–167). Malabar, FL: Robert E. Krieger Publishers. Chiang, C. L. (1984). Statistical inference regarding life table functions. In C. L. Chiang (Ed.), The life table and its applications (pp. 153–167). Malabar, FL: Robert E. Krieger Publishers.
11.
go back to reference National Research Council. (2010). Accounting for health and health care: Approaches to measuring the sources and costs of their improvement. Panel to Advance a research program on the Design of National Health Accounts, Committee on National Statistics, Division of Behavioral and Social Sciences and Education. Washington, DC: The National Academies Press. National Research Council. (2010). Accounting for health and health care: Approaches to measuring the sources and costs of their improvement. Panel to Advance a research program on the Design of National Health Accounts, Committee on National Statistics, Division of Behavioral and Social Sciences and Education. Washington, DC: The National Academies Press.
12.
go back to reference Jia, H., Zack, H. H., & Thompson, W. W. (2011). State quality-adjusted life expectancy for US adults from 1993 to 2008. Quality of Life Research, 20(6), 853–863.CrossRefPubMed Jia, H., Zack, H. H., & Thompson, W. W. (2011). State quality-adjusted life expectancy for US adults from 1993 to 2008. Quality of Life Research, 20(6), 853–863.CrossRefPubMed
13.
go back to reference Glasziou, P. P., Simes, R. J., & Gelber, R. D. (1990). Quality adjusted survival analysis. Statistics in Medicine, 9, 1259–1276.CrossRefPubMed Glasziou, P. P., Simes, R. J., & Gelber, R. D. (1990). Quality adjusted survival analysis. Statistics in Medicine, 9, 1259–1276.CrossRefPubMed
14.
go back to reference Shen, L. Z., Pulkstenis, E., & Moseyni, M. (1999). Estimation of mean quality adjusted survival time. Statistics in Medicine, 18, 1541–1554.CrossRefPubMed Shen, L. Z., Pulkstenis, E., & Moseyni, M. (1999). Estimation of mean quality adjusted survival time. Statistics in Medicine, 18, 1541–1554.CrossRefPubMed
15.
go back to reference Gong, Q., & Fang, L. (2012). Asymptotic properties of mean survival estimate based on the Kaplan–Meier curve with an extrapolated tail. Pharmaceutical Statistics, 11, 135–140.CrossRefPubMed Gong, Q., & Fang, L. (2012). Asymptotic properties of mean survival estimate based on the Kaplan–Meier curve with an extrapolated tail. Pharmaceutical Statistics, 11, 135–140.CrossRefPubMed
16.
go back to reference Stewart, S. T., Cutler, D. M., & Rosen, A. B. (2013). US trends in quality-adjusted life expectancy from 1987 to 2008: Combining national surveys to more broadly track the health of the nation. American Journal of Public Health, 103(11), e78–e87.CrossRefPubMedPubMedCentral Stewart, S. T., Cutler, D. M., & Rosen, A. B. (2013). US trends in quality-adjusted life expectancy from 1987 to 2008: Combining national surveys to more broadly track the health of the nation. American Journal of Public Health, 103(11), e78–e87.CrossRefPubMedPubMedCentral
17.
go back to reference Jia, H., Zack, M. M., & Thompson, W. W. (2013). The effects of diabetes, hypertension, asthma, heart disease, and stroke on quality-adjusted life expectancy. Value in Health, 16(1), 140–147.CrossRefPubMed Jia, H., Zack, M. M., & Thompson, W. W. (2013). The effects of diabetes, hypertension, asthma, heart disease, and stroke on quality-adjusted life expectancy. Value in Health, 16(1), 140–147.CrossRefPubMed
18.
go back to reference Jia, H., Zack, M. M., Thompson, W. W., & Dube, S. R. (2013). Quality-adjusted life expectancy (QALE) loss due to smoking in the United States. Quality of Life Research, 22(1), 27–35.CrossRefPubMed Jia, H., Zack, M. M., Thompson, W. W., & Dube, S. R. (2013). Quality-adjusted life expectancy (QALE) loss due to smoking in the United States. Quality of Life Research, 22(1), 27–35.CrossRefPubMed
19.
go back to reference Lee, H. Y., Hwang, J. S., Jeng, J. S., & Wang, J. D. (2010). Quality-adjusted life expectancy (QALE) and loss of QALE for patients with ischemic stroke and intracerebral hemorrhage: A 13-year follow-up. Stroke, 41(4), 739–744.CrossRefPubMed Lee, H. Y., Hwang, J. S., Jeng, J. S., & Wang, J. D. (2010). Quality-adjusted life expectancy (QALE) and loss of QALE for patients with ischemic stroke and intracerebral hemorrhage: A 13-year follow-up. Stroke, 41(4), 739–744.CrossRefPubMed
20.
go back to reference Oyunbileg, S., Wang, J. D., Sumberzul, N., Chang, Y. Y., & Erdenchimeg, E. (2011). Health impact of pneumoconiosis in Mongolia: Estimation of losses in life expectancy and quality adjusted life expectancy. American Journal of Indian Medicine, 54(4), 285–292.CrossRef Oyunbileg, S., Wang, J. D., Sumberzul, N., Chang, Y. Y., & Erdenchimeg, E. (2011). Health impact of pneumoconiosis in Mongolia: Estimation of losses in life expectancy and quality adjusted life expectancy. American Journal of Indian Medicine, 54(4), 285–292.CrossRef
21.
go back to reference Richardson, G., & Manca, A. (2004). Calculation of quality adjusted life years in the published literature: A review of methodology and transparency. Health Economics, 12, 1203–1210.CrossRef Richardson, G., & Manca, A. (2004). Calculation of quality adjusted life years in the published literature: A review of methodology and transparency. Health Economics, 12, 1203–1210.CrossRef
22.
go back to reference Ong, K. L., Wu, B. J., Cheung, B. M., Barter, P. J., & Rye, K. A. (2013). Arthritis: Its prevalence, risk factors, and association with cardiovascular diseases in the United States, 1999 to 2008. Annals of Epidemiology, 23(2), 80–86.CrossRefPubMed Ong, K. L., Wu, B. J., Cheung, B. M., Barter, P. J., & Rye, K. A. (2013). Arthritis: Its prevalence, risk factors, and association with cardiovascular diseases in the United States, 1999 to 2008. Annals of Epidemiology, 23(2), 80–86.CrossRefPubMed
23.
go back to reference Heron, M. (2015). Deaths: Leading causes for 2011. National Vital Statistics Reports, 64(7), 1–96. Heron, M. (2015). Deaths: Leading causes for 2011. National Vital Statistics Reports, 64(7), 1–96.
24.
go back to reference U.S. Burden of Disease Collaborators. (2013). The state of US health, 1990–2010: Burden of diseases, injuries, and risk factors. JAMA, 310(6), 591–608.CrossRef U.S. Burden of Disease Collaborators. (2013). The state of US health, 1990–2010: Burden of diseases, injuries, and risk factors. JAMA, 310(6), 591–608.CrossRef
27.
go back to reference Centers for Disease Control and Prevention. (2000). Measuring healthy days: Population assessment of health-related quality of life. U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion. Division of Adult and Community Health. http://www.cdc.gov/hrqol/pdfs/mhd.pdf. Accessed 20 July 2015. Centers for Disease Control and Prevention. (2000). Measuring healthy days: Population assessment of health-related quality of life. U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion. Division of Adult and Community Health. http://​www.​cdc.​gov/​hrqol/​pdfs/​mhd.​pdf. Accessed 20 July 2015.
28.
go back to reference Jia, H., & Lubetkin, E. I. (2008). Estimating EuroQol EQ-5D scores from population healthy days data. Medical Decision Making, 28(4), 491–499.CrossRefPubMed Jia, H., & Lubetkin, E. I. (2008). Estimating EuroQol EQ-5D scores from population healthy days data. Medical Decision Making, 28(4), 491–499.CrossRefPubMed
29.
go back to reference Jia, H., Zack, M. M., Moriarty, D. G., & Fryback, D. G. (2011). Predicting the EuroQol Group’s EQ-5D Index from CDC’s “Healthy Days” in a US sample. Medical Decision Making, 31(1), 174–185.CrossRefPubMed Jia, H., Zack, M. M., Moriarty, D. G., & Fryback, D. G. (2011). Predicting the EuroQol Group’s EQ-5D Index from CDC’s “Healthy Days” in a US sample. Medical Decision Making, 31(1), 174–185.CrossRefPubMed
30.
go back to reference Kroenke, K., Strine, T. W., Spitzer, R. L., Williams, J. B., Berry, J. T., & Mokdad, A. H. (2009). The PHQ-8 as a measure of current depression in the general population. Journal of Affective Disorders, 114(1–3), 163–173.CrossRefPubMed Kroenke, K., Strine, T. W., Spitzer, R. L., Williams, J. B., Berry, J. T., & Mokdad, A. H. (2009). The PHQ-8 as a measure of current depression in the general population. Journal of Affective Disorders, 114(1–3), 163–173.CrossRefPubMed
31.
go back to reference Austin, P. C. (2011). An introduction to propensity score methods for reducing the effects confounding in observational studies. Multivariate Behavioral Research, 46(3), 399–424.CrossRefPubMedPubMedCentral Austin, P. C. (2011). An introduction to propensity score methods for reducing the effects confounding in observational studies. Multivariate Behavioral Research, 46(3), 399–424.CrossRefPubMedPubMedCentral
32.
go back to reference Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., & Murray, C. J. (2013). Burden of depressive disorders by country, sex, age, and year: Findings from the global burden of disease study. PLoS Medicine, 10(11), e1001547.CrossRefPubMedPubMedCentral Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., & Murray, C. J. (2013). Burden of depressive disorders by country, sex, age, and year: Findings from the global burden of disease study. PLoS Medicine, 10(11), e1001547.CrossRefPubMedPubMedCentral
33.
go back to reference Jia, H., Zack, M. M., Thompson, W. W., Crosby, A. E., & Gottesman, I. I. (2015). Impact of depression on quality-adjusted life expectancy (QALE) directly as well as indirectly through suicide. Social Psychiatry and Psychiatric Epidemiology, 50(6), 939–949.CrossRefPubMedPubMedCentral Jia, H., Zack, M. M., Thompson, W. W., Crosby, A. E., & Gottesman, I. I. (2015). Impact of depression on quality-adjusted life expectancy (QALE) directly as well as indirectly through suicide. Social Psychiatry and Psychiatric Epidemiology, 50(6), 939–949.CrossRefPubMedPubMedCentral
36.
go back to reference Welch, H. G., & Black, W. C. (2010). Overdiagnosis in cancer. Journal of the National Cancer Institute, 102, 605–613.CrossRefPubMed Welch, H. G., & Black, W. C. (2010). Overdiagnosis in cancer. Journal of the National Cancer Institute, 102, 605–613.CrossRefPubMed
37.
go back to reference Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., et al. (2012). Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: A systematic analysis for the global burden of disease study 2010. Lancet, 380(9859), 2163–2196.CrossRefPubMed Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., et al. (2012). Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: A systematic analysis for the global burden of disease study 2010. Lancet, 380(9859), 2163–2196.CrossRefPubMed
38.
go back to reference Vogeli, C., Shields, A. E., Lee, T. A., Gibson, T. B., Marder, W. D., Weiss, K. B., et al. (2007). Multiple chronic conditions: Prevalence, health consequences, and implications for quality, care management, and costs. Journal of General Internal Medicine, 22(Suppl 3), 391–395.CrossRefPubMedPubMedCentral Vogeli, C., Shields, A. E., Lee, T. A., Gibson, T. B., Marder, W. D., Weiss, K. B., et al. (2007). Multiple chronic conditions: Prevalence, health consequences, and implications for quality, care management, and costs. Journal of General Internal Medicine, 22(Suppl 3), 391–395.CrossRefPubMedPubMedCentral
39.
go back to reference Seligman, F., & Nemeroff, C. B. (2015). The interface of depression and cardiovascular disease: Therapeutic implications. Annals of the New York Academy of Science, 1345(1), 25–35.CrossRef Seligman, F., & Nemeroff, C. B. (2015). The interface of depression and cardiovascular disease: Therapeutic implications. Annals of the New York Academy of Science, 1345(1), 25–35.CrossRef
Metagegevens
Titel
Impact of nine chronic conditions for US adults aged 65 years and older: an application of a hybrid estimator of quality-adjusted life years throughout remainder of lifetime
Auteurs
Haomiao Jia
Erica I. Lubetkin
Publicatiedatum
01-08-2016
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 8/2016
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-016-1226-5